- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04041960
Effects of TBS on Reading in Adult Struggling Readers
Examining the Effects of Theta Burst Stimulation on the Neural Network Associated With Reading in Adult Struggling Readers
Study Overview
Status
Intervention / Treatment
Detailed Description
Subjects will come in for up to 2 sessions, each lasting between 1 - 4 hours. Subjects will complete reading and cognitive tasks associated with reading, and receive TMS as well as 2 MRI brain scans, in order to assess brain regions important to reading.
Initial, basic screening including MRI and TMS safety screening will be conducted over the phone during the recruitment phone call and/or screening forms will be emailed to prospective subjects for their review. Those individuals that qualify will be scheduled for session 1. Session 1 will take between 1 and 3 hours. Subjects who pass health/MRI/TMS screening will complete cognitive/reading screening measures as well as the demographic information survey. They will also be trained on the MRI and TMS procedures. If all screening criteria is met, subjects will be asked to return for a second session which will include the MRI and TMS portions of the study.
Session 2 will take place on a separate day and consist of renewal of the health/MRI/TMS screening forms prior to the MRI scan or TMS administration. The baseline MRI portion of the session will last approximately 1.5 hours including screening, training, and scan time. The MRI scan will be followed by the TMS portion which will last approximately 45 minutes. The post-TMS MRI will take place immediately following the TMS session and will last approximately 45 minutes. Reading assessments will be administered before the baseline MRI and again after TMS stimulation/before post-TMS MRI, each lasting approximately 10 minutes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30318
- Center for Advanced Brain Imaging
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must meet the study reading criteria based on their reading and reading-related screening test results
- native speakers of English
- Right handed
- minimum of low average intellectual functioning (SS>=80) on at least one subscale on the Wechsler Abbreviated Scale of Intelligence-2
Exclusion Criteria:
- hearing deficits (>25dB at 500+ Hz), visual deficits (>20/40), serious emotional problems, certain neurological conditions (e.g., uncontrolled seizure disorders)
- Braces on teeth, a cardiac pacemaker; hearing aid; other metal in their body or eyes (which may include certain metallic-embedded tattoos), including but not limited to pins, screws, shrapnel, plates, dentures or other metal objects
- TMS or MRI Screening and Contraindication Forms which do not pass technician review
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: SMG
Brain region targeted with transcranial magnetic stimulation: superamarginal gyrus
|
The TMS protocol to be used, excitatory intermittent theta burst stimulation (iTBS), has been shown to have minimal risk in children as young as 6 (Hong et al., 2015), as well as adults (Huang et al., 2005).
This stimulation paradigm uses a series of theta burst stimulation (TBS) units.
Each unit consists of 3 pulses of stimulation given at 50 Hz (Huang et al., 2005).
Excitatory iTBS consists of 20 sets of 10 TBS units (2 second duration) repeated every 10 seconds for a total of 190 seconds.
One session of excitatory stimulation delivers a total of 600 pulses.
|
EXPERIMENTAL: MTG
Brain region targeted with transcranial magnetic stimulation: middle temporal gyrus
|
The TMS protocol to be used, excitatory intermittent theta burst stimulation (iTBS), has been shown to have minimal risk in children as young as 6 (Hong et al., 2015), as well as adults (Huang et al., 2005).
This stimulation paradigm uses a series of theta burst stimulation (TBS) units.
Each unit consists of 3 pulses of stimulation given at 50 Hz (Huang et al., 2005).
Excitatory iTBS consists of 20 sets of 10 TBS units (2 second duration) repeated every 10 seconds for a total of 190 seconds.
One session of excitatory stimulation delivers a total of 600 pulses.
|
ACTIVE_COMPARATOR: Vertex
Brain region targeted with transcranial magnetic stimulation (none associated): Vertex
|
The TMS protocol to be used, excitatory intermittent theta burst stimulation (iTBS), has been shown to have minimal risk in children as young as 6 (Hong et al., 2015), as well as adults (Huang et al., 2005).
This stimulation paradigm uses a series of theta burst stimulation (TBS) units.
Each unit consists of 3 pulses of stimulation given at 50 Hz (Huang et al., 2005).
Excitatory iTBS consists of 20 sets of 10 TBS units (2 second duration) repeated every 10 seconds for a total of 190 seconds.
One session of excitatory stimulation delivers a total of 600 pulses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in lexical decision making
Time Frame: 10 minutes after TMS
|
Subjects will complete one computerized lexical decision making task before and after TMS stimulation in order to assess change in lexical decision making ability 10mins post stimulation.
Subjects will see a word cue on the screen and asked to judge with a button press if the word cue is a "real word" or "not a real word."
|
10 minutes after TMS
|
Change in real-word reading efficiency
Time Frame: 5 minutes after TMS
|
Subjects will complete a timed real word reading task before and after TMS stimulation in order to assess change in word reading ability 5mins post stimulation.;
Subjects will read a list of words as quickly and as accurately as possible.
|
5 minutes after TMS
|
Change in Pseudoword reading efficiency
Time Frame: 5 to 10 minutes after TMS
|
Subjects will complete a pseudoword reading task before and after TMS stimulation in order to assess change in pseudoword reading ability 5mins post stimulation.
Subjects will read a list of pseudowords as quickly and as accurately as possible.
|
5 to 10 minutes after TMS
|
Change in phonemic decoding
Time Frame: 5 to 10 minutes after TMS
|
Subjects will complete one computerized lexical phonemic decoding task before and after TMS stimulation in order to assess change in phonemic decoding ability 10mins post stimulation.
Subjects will see a non-real word cue on the screen and be asked to judge with a button press if the non-real word cue can be pronounced like ("sounds like") a real word or not a real word.
|
5 to 10 minutes after TMS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in function of neural reading network
Time Frame: 20 minutes after TMS
|
Subjects will complete a functional MRI task requiring the subject to read a word and identify if it matches a picture present on the screen.
This will be used to assess the effectiveness of the TMS on the targeted reading network.
|
20 minutes after TMS
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H18271
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Developmental Reading Disorder
-
University of Heidelberg Medical CenterUnknownDyslexia | Reading Disability | Reading Disorder | Developmental Reading DisorderGermany
-
Georgia State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingDyslexia | Dyslexia, Developmental | Learning; Developmental Disorder, ReadingUnited States
-
Ohio State UniversityNationwide Children's HospitalRecruitingDevelopmental Language Disorder | Reading; DifficultUnited States
-
University Hospital, ToursCompletedDyslexia | Developmental Reading DisorderFrance
-
IRCCS Eugenio MedeaUniversità degli studi di BergamoRecruiting
-
Federal University of São PauloConselho Nacional de Desenvolvimento Científico e Tecnológico; Instituto ABCDUnknownDifficult; Spelling, With Reading DisorderBrazil
-
Aix Marseille UniversitéUniversity of Roma La Sapienza; WHO Collaborating Centre for Maternal and Child...CompletedReading Disability
-
Stanford UniversityActive, not recruiting
-
University of Sao PauloCompleted
-
Sherine TambyrajaOhio State UniversityUnknown
Clinical Trials on Transcranial magnetic stimulation (TMS)
-
Emory UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Centre Hospitalier St AnneNot yet recruitingTreatment Resistant Schizophrenia
-
Northwestern UniversityCompletedHealthyUnited States
-
University of FloridaActive, not recruiting
-
Huashan HospitalUnknown
-
University of California, San DiegoNational Institutes of Health (NIH)RecruitingMajor Depressive DisorderUnited States, Australia
-
University of ManitobaRecruiting
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Beth Israel Deaconess Medical CenterTerminated
-
Northwestern UniversityCompleted